Recommendations for the measurement of the QT interval during the use of drugs for COVID-19 infection treatment. Updatable in accordance with the availability of new evidence | SpringerLink
Simplifying QT prolongation for busy clinicians | The College of Family Physicians of Canada
QT Interval Control to Prevent Torsades de Pointes during Use of Hydroxychloroquine and/or Azithromycin in Patients with COVID-19 - ABC Cardiol
Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19 | JACC: Clinical Electrophysiology
Comparative Pharmacodynamic Analysis of Q-T Interval Prolongation Induced by the Macrolides Clarithromycin, Roxithromycin, and Azithromycin in Rats | Antimicrobial Agents and Chemotherapy
Ventricular Arrhythmia Risk Due to Hydroxychloroquine-Azithromycin Treatment For COVID-19 - American College of Cardiology
QT interval and repolarization dispersion changes during the administration of hydroxychloroquine/chloroquine with/without azithromycin in early COVID 19 pandemic: A prospective observational study from two academic hospitals in Indonesia - Gumilang ...
Frontiers | QTc Prolongation Risk Evaluation in Female COVID-19 Patients Undergoing Chloroquine and Hydroxychloroquine With/Without Azithromycin Treatment
Absence of relevant QT interval prolongation in not critically ill COVID-19 patients | Scientific Reports
How to Diagnose and Manage QT Prolongation in Cancer Patients | JACC: CardioOncology
Measurement and Management of QT Interval Prolongation for General Physicians | SpringerLink
Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19 - ScienceDirect
Acute QT Interval Modifications During Hydroxychloroquine-Azithromycin Treatment in the Context of COVID-19 Infection - Mayo Clinic Proceedings
QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review - Heart Rhythm
HCQ Plus Azithromycin: A Dangerous Combination? | MedPage Today
The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin | Nature Medicine
QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin | SpringerLink
VisualAbstract: Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin | 2 Minute Medicine
Myth-busting: Azithromycin does not cause torsade de pointes or increase mortality
Frontiers | QTc Prolongation Risk Evaluation in Female COVID-19 Patients Undergoing Chloroquine and Hydroxychloroquine With/Without Azithromycin Treatment
Clinical aspects of drug-induced QT prolongation
Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine- azithromycin combination regimen - International Journal of Cardiology
QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019 - ScienceDirect
Risk Evaluation of Azithromycin-Induced QT Prolongation in Real-World Practice
FDA Drug Safety Communication: Azithromycin (Zithromax or Zmax) and the risk of potentially fatal heart rhythms
Congenital and Acquired Long QT Syndrome: A Pharmacist's Perspective
